Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02975869 · ClinicalTrials.gov registry record · NA
A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT02975869: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02975869 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 160 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02975869, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
This research study is evaluating the impact a collaborative palliative care and oncology team will have on the quality of life, symptoms, mood, and end of life outcomes of patients with acute myeloid leukemia (AML). Palliative care is a medical specialty focused on lessening (or "palliating") symptoms and assisting in coping with serious illness.
Interventions
- OTHER Palliative Care
- OTHER Standard Leukemia Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2026-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02975869
The ClinicalTrials.gov registry entry for NCT02975869 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Palliative Care is the first listed.
NCT02975869 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02975869 about?
NCT02975869 is a clinical study titled "A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia". This research study is evaluating the impact a collaborative palliative care and oncology team will have on the quality of life, symptoms, mood, and end of life outcomes of patients with acute myeloid leukemia (AML). Palliative care is a medical specialty focused on lessening (or "palliating") sympt...
What is the current status of trial NCT02975869?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2017-01-01. Estimated completion is 2026-01-01.
What interventions are being tested in trial NCT02975869?
The interventions under investigation include: Palliative Care (OTHER), Standard Leukemia Care (OTHER).
Who is sponsoring clinical trial NCT02975869?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.